Sequent Scientific Limited
Sequent Scientific Limited (SEQUENT.NS) Stock Overview
Explore Sequent Scientific Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
50.6B
P/E Ratio
120.94
EPS (TTM)
$1.63
ROE
0.06%
SEQUENT.NS Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Sequent Scientific Limited (SEQUENT.NS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 59.46, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $107.45.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 120.94 and a market capitalization of 50.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.